Wells Fargo’s Zimmer Biomet ZBH Stock Holding History

Wells Fargo’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-38,625	Closed	-$765K	–	7472
2020 Q4	$765K	Buy	38,625 +10,197	+36%	+$1.44M	﹤0.01%	4216
2020 Q3	$153K	Hold	28,428	–	–	﹤0.01%	5094
2020 Q2	$119K	Sell	28,428 -33,372	-54%	-$3.85M	﹤0.01%	5144
2020 Q1	$24K	Hold	61,800	–	–	﹤0.01%	5561
2019 Q4	$647K	Sell	61,800 -1,648	-3%	-$227K	﹤0.01%	4155
2019 Q3	$943K	Hold	63,448	–	–	﹤0.01%	3883
2019 Q2	$313K	Buy	+63,448	New	+$7.43M	﹤0.01%	4694
2019 Q1	–	Sell	-51,500	Closed	-$3K	–	6526
2018 Q4	$3K	Hold	51,500	–	–	﹤0.01%	6165
2018 Q3	$519K	Hold	51,500	–	–	﹤0.01%	4411
2018 Q2	$139K	Buy	+51,500	New	+$5.61M	﹤0.01%	5213

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wells Fargo's ZBH Position: Q1 2026 in Review

Wells Fargo reduced its Zimmer Biomet (ZBH) stake by 20% in Q1 2026, selling an estimated $4.09M and leaving 179,488 shares worth $16.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1665.

Wells Fargo first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $372M in Q2 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Wells Fargo held 179,488 shares of Zimmer Biomet worth $16.2M as of Q1 2026.
Wells Fargo sold 44,601 Zimmer Biomet shares in Q1 2026, an estimated $4.09M.
Zimmer Biomet made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #1665 holding.
Wells Fargo first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
Wells Fargo's Zimmer Biomet position peaked at $372M in Q2 2021.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.